π΅οΈ Bioventus Inc. ($BVS)
SEC insider & ownership activity, last 12 months Β· CIK 1665988 Β· every row links its SEC filing
Over the last 12 months insiders sold $312K with no open-market buying against it. McMurry-Heath Michelle sold $237K in discretionary trades (NovβMar). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) Β· 2 sellers, $312K (3 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| McMurry-Heath Michelle | 0 | β | 2 | $237K | Mar 11, 2026 |
| Guy P. Nohra | 0 | β | 1 | $76K | Dec 4, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9.0% | 13G | Feb 13, 2026 | filing β | |
| Wilmot B. Harkey | 9.0% | 13G | Feb 13, 2026 | filing β | |
| Daniel Mack | 9.0% | 13G | Feb 13, 2026 | filing β | |
| Blackrock, Inc. | 5.0% | Class A | 13G | Jul 27, 2026 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| McMurry-Heath Michelle | $106K | Mar 11, 2026 | filing β |
| Guy P. Nohra | $76K | Dec 4, 2025 | filing β |
| McMurry-Heath Michelle | $200K | Nov 7, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 3, 2026 | filing β |
| Reg FD disclosure (7.01) | May 21, 2026 | filing β |
| Earnings (2.02) | May 6, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing β |
| Earnings (2.02) | Mar 5, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing β |
| Officer/director changes (5.02) | Nov 14, 2025 | filing β |
| Earnings (2.02) | Nov 4, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing β |
| Earnings (2.02) | Aug 6, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 6, 2025 | filing β |
| Material agreement (1.01) | Jul 31, 2025 | filing β |
| New financial obligation (2.03) | Jul 31, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Jul 31, 2025 | filing β |
| Other events (8.01) | Jul 30, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Jul 30, 2025 | filing β |